Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-021083

Head of Development sold 517 shares at $133.55 ($69,045)

  • Head of Development gave up 807 shares (to pay taxes)
  • Head of Development acquired 1,669 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Singhal Priya · Head of Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-29 Exercise or conversion : show line 1 in the form 10b5-1 +1,669 7,096.14 D
2025-08-29 Shares withheld for taxes : show line 2 in the form 10b5-1 −807 $132.22 $106,702 6,289.14 D
2025-09-02 Sale : show line 3 in the form 10b5-1 −517 $133.55 $69,045 5,772.14 D
Open-market sales · 517 sh · avg $133.55 · $69,045

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-29 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit −1,669 0 D
Loading xslF345X05/form4.xml…